Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 9, 2002, Pages 1409-1414

  Rodríguez, Cristina ^a   Raposo, Berta ^a   Martínez González, José ^a   Casaní, Laura ^a   Badimon, Lina ^a,b  

^a CSIC   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Endothelial cells; Hypercholesterolemia; Low density lipoproteins; Lysyl oxidase; Vascular permeability

Indexed keywords

LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CROSS LINKING; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AORTA; ARTERIES; ARTERIOSCLEROSIS; BENZIMIDAZOLES; CAPILLARY PERMEABILITY; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION PROFILING; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MODELS, ANIMAL; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-LYSINE 6-OXIDASE; RNA, MESSENGER; SWINE; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0036736755     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000033818.21748.99     Document Type: Article

References (40)

1. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients
2. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide synthase mRNA and protein levels in endothelial cells
3. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: Balance between transcriptional and posttranscriptional regulation
4. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells
5. Atherogenic levels of low density lipoprotein alter the permeability and composition of the endothelial barrier
6. Cell surface monoamine oxidases: Enzymes in search of a function
7. Properties and function of lysyl oxidase
8. Expression of gene rrg is associated with reversion of NIH3T3 transformed by LTR-c-H-ras
9. Lysyl oxidase and rrg messenger RNA
10. Induction of human monocyte motility by lysyl oxidase
11. A novel human cDNA with a predicted protein similar to lysyl oxidase maps to chromosome 15q24-q25
12. A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase
13. The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues
14. Cloning and characterization of a human lysyl oxidase-like 3 gene (hLOXL3)
15. Cloning and characterization of a fourth human lysyl oxidase isoenzyme
16. Type IX Ehlers-Danlos syndrome and Menkes syndrome: The decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein
17. Extracellular matrix deposition, lysyl oxidase expression and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat
18. Lysyl oxidase: Properties, regulation and multiple functions in biology
19. Lysyl oxidase activates the transcription activity of human collagen III promoter
20. Regulation of lysyl oxidase by interferon-γ in rat aortic smooth muscle cells
21. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues: Implications for homocystinuria
22. LDL downregulates CYP51 in porcine vascular endothelial cells and in the arterial wall through a sterol regulatory element binding protein-2-dependent mechanism
23. Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk
24. Platelet deposition on eroded vessel wall at stenotic shear rate is inhibited by lipid-lowering treatment with atorvastatin
25. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples
26. 2-adrenoceptors
27. Collagen cross-link synthesis in cultured vascular endothelium
28. Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: Effects of TGF-β1 and serum deprivation
29. Regulation of lysyl oxidase and cyclooxygenase expression in human lung fibroblasts: Interactions among TGF-β, IL-1β and prostaglandin E
30. Epigenetic inhibition of lysyl oxidase transcription alter transformation by ras oncogene
31. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures
32. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity
33. Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase
34. Endothelial cell monolayer dysfunction caused by oxidized low density lipoprotein: Attenuation by oleic acid
35. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
36. Early changes in the arterial wall of chickens fed a cholesterol diet
37. Changes in aortic lysyl oxidase activity in diet-induced atherosclerosis in the rabbit
38. Usefulness and limitations of animals models of venous thrombosis
39. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-I expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels